2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Cifra de Afaceri - Ron | 553.594 | 543.647 | 353.906 | 316.324 | 425.719 | 393.609 | 331.980 | 401.584 | 439.541 | 501.917 |
Venituri Totale - Ron | 553.638 | 544.279 | 619.787 | 316.324 | 425.722 | 394.911 | 332.005 | 404.653 | 439.564 | 501.990 |
Cheltuieli Totale - Ron | 542.211 | 570.356 | 594.223 | 425.838 | 381.971 | 272.061 | 339.061 | 489.308 | 371.589 | 412.361 |
Profit/Pierdere Brut - Ron | 11.427 | -26.077 | 25.564 | -109.514 | 43.751 | 122.850 | -7.056 | -84.655 | 67.975 | 89.629 |
Profit/Pierdere Net - Ron | 8.466 | -29.552 | 19.620 | -111.022 | 39.494 | 118.914 | -13.265 | -88.701 | 63.579 | 85.553 |
Salariati | 2 | 0 | 2 | 3 | 3 | 2 | 2 | 1 | 1 | 1 |
Verifica rapoartele financiare pentru firma - E&A Pharma Grup Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Active Imobilizate | 48.488 | 47.648 | 0 | 0 | 0 | 0 | 183.374 | 124.066 | 74.572 | 29.725 |
Active Circulante | 498.182 | 180.925 | 206.447 | 132.242 | 192.053 | 214.401 | 149.357 | 123.218 | 158.285 | 261.158 |
Stocuri | 269.687 | 105.140 | 24.028 | 0 | 0 | 18.650 | 14.017 | -1.679 | 6.284 | 54.347 |
Creante | 89.320 | 37.409 | 9.148 | 114.277 | 175.013 | 190.366 | 132.602 | 120.708 | 148.487 | 201.632 |
Casa si conturi | 139.175 | 38.376 | 173.271 | 17.965 | 17.040 | 5.385 | 2.738 | 4.189 | 3.514 | 5.179 |
Capitaluri Proprii | 164.459 | 134.906 | 125.973 | 31.570 | 71.064 | 189.978 | 176.713 | 88.012 | 151.591 | 237.144 |
Capital Social | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 |
Datorii | 382.211 | 93.667 | 80.474 | 100.672 | 120.989 | 24.423 | 156.018 | 159.272 | 81.266 | 53.739 |
Venituri in Avans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Curs valutar - RON | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
CAEN Principal | "4773 - 4773" | |||||||||
CAEN An Financiar |
4773
|
Abonamente Rapoarte Financiare
Poti verifica nelimitat situatia financiara a firmelor raportata la industria din care face parte, limitele de creditare si riscul de insolventa si de oprire al conturilor.
Comentarii - E&A Pharma Grup Srl